Identification and Differentiation of Breast Masses by Vibro-Acoustography
25 Years
N/A
Female
Breast Cancer
Trial Information
Identification and Differentiation of Breast Masses by Vibro-Acoustography
OBJECTIVES:
- To study in vivo detection of breast masses by vibro-acoustography (VA) imaging.
- To evaluate the performance of VA imaging in differentiating between benign and
malignant breast masses identified as BI-RADS 4 or 5.
OUTLINE: Patients undergo clinical mammography of the breast, followed by
vibro-acoustography (VA) imaging using ultrasonography over 90 minutes. Patients may also
undergo further imaging using clinical ultrasonography.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Known breast mass identified as BI-RADS 4 or 5
- Patients with proven breast cancer who are undergoing chemotherapy before
surgery are eligible
- Hormone receptor status not specified
PATIENT CHARACTERISTICS:
- Female
- Menopausal status not specified
- Not pregnant
- No condition that does not allow proper use of study imaging devices
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Detection and differentiation of breast masses with an estimated specificity of ≥ 70% using vibro-acoustography (VA) imaging
Outcome Time Frame:
5 to 10 minutes for Breast VA imaging
Safety Issue:
No
Principal Investigator
Azra Alizad, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Mayo Clinic
Authority:
United States: Institutional Review Board
Study ID:
284-06
NCT ID:
NCT00627614
Start Date:
March 2006
Completion Date:
May 2013
Related Keywords:
- Breast Cancer
- stage I breast cancer
- stage II breast cancer
- stage IIIA breast cancer
- stage IIIB breast cancer
- stage IIIC breast cancer
- stage IV breast cancer
- Breast Neoplasms
Name | Location |
|---|---|
| Mayo Clinic Cancer Center | Rochester, Minnesota 55905 |
